Evidence map›Paper›PMID 29691274›Full record

ArticleBMJ case reports2018

Negative myoclonus secondary to paroxetine intake.

Pedro Correia, Joana Afonso Ribeiro, Conceição Bento, Francisco Sales

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Drug-Induced Myoclonus: A Systematic Review.Medicina (Kaunas, Lithuania) · 2025
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pedro CorreiaEpilepsy Unit, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.ORCID http://orcid.org/0000-0002-0720-7616
Joana Afonso RibeiroEpilepsy Unit, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Conceição BentoEpilepsy Unit, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Francisco SalesEpilepsy Unit, Department of Neurology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outside the context of overdose and serotonin syndrome, seizures and myoclonic movements attributed to selective serotonin reuptake inhibitors (SSRIs) are rare and poorly documented. We present a 77-year-old man, with no history of epilepsy, presenting in the emergency department with whole body jerks since that morning. Two days earlier, due to a prescription mistake, he was started on paroxetine 20 mg instead of his usual fluoxetine 20 mg. The patient's electroencephalogram (EEG), performed in the emergency department, revealed a bilateral synchronous parieto-occipital fast spike activity pattern, which correlated consistently with negative myoclonus. Two days after stopping paroxetine, the patient presented no seizures and no abnormalities in the EEG. We present an EEG documented case of drug-induced seizures, with a bilateral parieto-occipital pattern, secondary to paroxetine intake. A hyperexcitability of the primary somatosensory cortex inhibiting primary motor cortex output could explain the electroclinical correlation.

Indexed as

AgedElectroencephalographyFluoxetineHumansMaleMedical ErrorsMyoclonusParoxetineSeizuresSelective Serotonin Reuptake InhibitorsSomatosensory CortexTreatment OutcomeFluoxetineParoxetineSelective Serotonin Reuptake Inhibitorsclinical neurophysiologyepilepsy and seizuresneurology (drugs and medicines)unwanted effects / adverse reactions

Identifiers

PMID29691274
PMCPMC5926597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.